Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice
about
Potential Use of Antimicrobial Peptides as Vaginal Spermicides/MicrobicidesAntibiotic treatment for Helicobacter pylori: Is the end coming?Differential cathelicidin expression in duodenal and gastric biopsies from Tanzanian and German patients.Role of the HefC efflux pump in Helicobacter pylori cholesterol-dependent resistance to ceragenins and bile saltsCathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeabilitySurvival in hostile territory: the microbiota of the stomach.Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles.Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection.In vitro evaluation of the potential for resistance development to ceragenin CSA-13.Sporicidal activity of ceragenin CSA-13 against Bacillus subtilis.Mechanistic and structural basis of bioengineered bovine Cathelicidin-5 with optimized therapeutic activity.Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches.Nontraditional therapies to treat Helicobacter pylori infection.Potential synergy activity of the novel ceragenin, CSA-13, against carbapenem-resistant Acinetobacter baumannii strains isolated from bacteremia patients.Helicobacter pylori induces increased expression of the vitamin d receptor in immune responses.β-Defensins in the Fight against Helicobacter pylori.Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections.CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway.
P2860
Q26765450-47E04EE1-1133-4AC7-85A7-7B6EAB158E30Q26777623-4473DE68-5AF4-48EF-8DB5-20EBEB676D0EQ33979642-B33D3601-BA36-49B4-B770-2AC24A5E379CQ34484733-C0001100-5E86-4A5E-845B-3E7D2E6DFA85Q34501689-11CE1F85-3A79-4D18-B7AA-0B1163784FD5Q34780560-9BA11865-DAC7-424B-AA90-F864C7A3AFD7Q35689986-C3F9D6DF-E399-422C-B5DC-1B85F6507CA9Q36076086-BBB17048-8FB4-4F3C-840D-B04870A51E84Q36308072-8D8E415D-4815-40A6-AACF-2E239A682A31Q37704569-D4C87A20-E935-435D-AF71-73551B656C63Q37712921-5FEFA7C1-8229-4B12-8CEF-C680E45E5201Q37877621-EDDF1C93-5CA7-46B5-9E6E-CFC349995929Q38200572-B9068D6B-6A1C-4170-903C-2DFAAD7B74BDQ38918568-2E78393C-E118-4A80-998D-C546A001BA92Q39067394-5657D8E2-FCB5-4522-96D2-147CE44B9E8CQ39168125-DBC94CA4-DC90-4541-AED6-EBFA3F5415D8Q41981409-9398C1BE-ADC4-4A87-B50E-B7EA5D62872FQ46051469-9EAA5AC2-E275-4277-8455-2D4709F4D506
P2860
Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Bactericidal activities of the ...... ori in simulated gastric juice
@ast
Bactericidal activities of the ...... ori in simulated gastric juice
@en
type
label
Bactericidal activities of the ...... ori in simulated gastric juice
@ast
Bactericidal activities of the ...... ori in simulated gastric juice
@en
prefLabel
Bactericidal activities of the ...... ori in simulated gastric juice
@ast
Bactericidal activities of the ...... ori in simulated gastric juice
@en
P2093
P2860
P356
P1433
P1476
Bactericidal activities of the ...... ori in simulated gastric juice
@en
P2093
Andrzej Namiot
David E Fein
Paul A Janmey
Paul B Savage
Scott Diamond
Zbigniew Namiot
P2860
P2888
P356
10.1186/1471-2180-9-187
P577
2009-09-03T00:00:00Z
P5875
P6179
1014394749